Basic Information
Zilico is committed to developing the next generation of cancer diagnostic technology, providing real-time diagnosis for cervical cancer. Zilico is developing the next generation of cancer diagnostic methods, offering real-time diagnosis for cervical cancer and reducing the inherent subjectivity of existing methods. Two applications are under development: the first for the referral market and the second for the screening market.
Zilico Ltd
Manchester,England,United Kingdom
15~50 people
January 01, 2006
info@zilico.co.uk

